Discrepancy Between Genetically Predicted and Observed BMI Predicts Incident Type 2 Diabetes.

Tae-Min Rhee, Jaewon Choi, Hyunsuk Lee, Jordi Merino, Jun-Bean Park, Soo Heon Kwak
Author Information
  1. Tae-Min Rhee: Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Republic of Korea.
  2. Jaewon Choi: Innovative Biomedical Technology Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. ORCID
  3. Hyunsuk Lee: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea. ORCID
  4. Jordi Merino: Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  5. Jun-Bean Park: Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  6. Soo Heon Kwak: Innovative Biomedical Technology Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. ORCID

Abstract

OBJECTIVE: Obesity is a key predictor of type 2 diabetes (T2D). However, metabolic complications are not solely due to increased BMI. We hypothesized that differences between genetically predicted BMI and observed BMI (BMI-diff) could reflect deviation from individual set point and may predict incident T2D.
RESEARCH DESIGN AND METHODS: From the UK Biobank cohort, we selected participants of European ancestry without T2D (n = 332,154). The polygenic risk score for BMI was calculated via Bayesian regression and continuous shrinkage priors (PRS-CS). According to the BMI-diff, the 10-year risk of T2D was assessed using multivariable Cox proportional hazards model. Independent data from the Korean Genome and Epidemiology Study (KoGES) cohort from South Korea (n = 7,430) were used for replication.
RESULTS: Participants from the UK Biobank were divided into train (n = 268,041) and test set (n = 115,119) to establish genetically predicted BMI. In the test set, the genetically predicted BMI explained 7.1% of the variance of BMI, and there were 3,599 T2D cases (3.1%) during a 10-year follow-up. Participants in the higher quintiles of BMI-diff (more obese than genetically predicted) had significantly higher risk of T2D than those in the lowest quintile after adjusting for observed BMI: the adjusted hazard ratio of the 1st quintile (vs. 5th quintile) was 1.61 (95% CI 1.26-2.05, P < 0.001). Results were consistent among individuals in the KoGES study. Moreover, higher BMI than predicted was associated with impaired insulin sensitivity.
CONCLUSIONS: Having a higher BMI than genetically predicted is associated with an increased risk of T2D. These findings underscore the potential to reassess T2D risk based on individual levels of obesity using genetic thresholds for BMI.

References

  1. Diabetologia. 1991 Dec;34(12):877-90 [PMID: 1778353]
  2. Eur J Epidemiol. 2018 Nov;33(11):1113-1123 [PMID: 30117031]
  3. Nat Genet. 2016 Oct;48(10):1279-83 [PMID: 27548312]
  4. EBioMedicine. 2022 Dec;86:104383 [PMID: 36462406]
  5. Nature. 2015 Oct 1;526(7571):82-90 [PMID: 26367797]
  6. Diabetes. 2015 Jul;64(7):2299-309 [PMID: 26106187]
  7. J Clin Invest. 2021 Feb 15;131(4): [PMID: 33586681]
  8. Diabetes Res Clin Pract. 2017 Oct;132:36-44 [PMID: 28783531]
  9. PLoS Med. 2015 Mar 31;12(3):e1001779 [PMID: 25826379]
  10. Br J Cancer. 2021 Dec;125(12):1718-1725 [PMID: 34552203]
  11. Nat Commun. 2015 Sep 14;6:8111 [PMID: 26368830]
  12. Diabetes Care. 2022 May 1;45(5):1260-1267 [PMID: 35287165]
  13. Nature. 2014 Jun 5;510(7503):84-91 [PMID: 24899308]
  14. Int J Epidemiol. 2017 Apr 1;46(2):e20 [PMID: 27085081]
  15. Lancet. 2018 Feb 10;391(10120):541-551 [PMID: 29221645]
  16. J Epidemiol Glob Health. 2020 Mar;10(1):107-111 [PMID: 32175717]
  17. Lancet Diabetes Endocrinol. 2016 Jan;4(1):27-34 [PMID: 26577716]
  18. World J Diabetes. 2015 May 15;6(4):613-20 [PMID: 25987958]
  19. Curr Diab Rep. 2018 Aug 18;18(10):85 [PMID: 30121879]
  20. Diabetes Care. 2011 Jun;34(6):1424-30 [PMID: 21602431]
  21. Nat Genet. 2021 Oct;53(10):1415-1424 [PMID: 34594039]
  22. Cell Genom. 2022 Oct 05;2(10):100189 [PMID: 36777999]
  23. Clin Sci (Lond). 2015 Apr;128(7):405-10 [PMID: 25515001]
  24. Nature. 2018 Oct;562(7726):203-209 [PMID: 30305743]
  25. Nat Commun. 2019 Apr 16;10(1):1776 [PMID: 30992449]
  26. Curr Obes Rep. 2020 Jun;9(2):109-120 [PMID: 32301039]
  27. Ann N Y Acad Sci. 2013 Apr;1281:64-91 [PMID: 23551121]
  28. Cell. 2019 Apr 18;177(3):587-596.e9 [PMID: 31002795]
  29. Nature. 2015 Feb 12;518(7538):197-206 [PMID: 25673413]

Grants

  1. U01 HG011723/NHGRI NIH HHS
  2. 23212MFDS202/Korean Ministry of Food and Drug Safety
  3. RS-2023-00262002/Korean Ministry of Science and ICT
  4. FAIN# U01HG011723/NHGRI NIH HHS

MeSH Term

Humans
Diabetes Mellitus, Type 2
Body Mass Index
Male
Female
Middle Aged
Adult
Obesity
Aged
United Kingdom

Word Cloud

Created with Highcharts 10.0.0BMIT2Dpredictedgeneticallyriskn=higherBMI-diffsetquintile2increasedobservedindividualUKBiobankcohort10-yearusingKoGES7Participantstest1%31associatedOBJECTIVE:ObesitykeypredictortypediabetesHowevermetaboliccomplicationssolelyduehypothesizeddifferencesreflectdeviationpointmaypredictincidentRESEARCHDESIGNANDMETHODS:selectedparticipantsEuropeanancestrywithout332154polygenicscorecalculatedviaBayesianregressioncontinuousshrinkagepriorsPRS-CSAccordingassessedmultivariableCoxproportionalhazardsmodelIndependentdataKoreanGenomeEpidemiologyStudySouthKorea430usedreplicationRESULTS:dividedtrain268041115119establishexplainedvariance599casesfollow-upquintilesobesesignificantlylowestadjustingBMI:adjustedhazardratio1stvs5th6195%CI26-205P<0001ResultsconsistentamongindividualsstudyMoreoverimpairedinsulinsensitivityCONCLUSIONS:findingsunderscorepotentialreassessbasedlevelsobesitygeneticthresholdsDiscrepancyGeneticallyPredictedObservedPredictsIncidentTypeDiabetes

Similar Articles

Cited By (1)